Sunshine Biopharma, Inc.
Sunshine Biopharma is a micro-cap biopharmaceutical company with minimal political engagement and no measurable government dependence or regulatory lobbying activity.
BusinessWhat SBFM does
Sunshine Biopharma operates as a development-stage biopharmaceutical company focused on drug discovery and development. Revenue streams are likely limited or pre-commercial, with primary funding from capital raises rather than product sales or government contracts.
12 months past · 3 months futureSBFM activity timeline
Lifetime Government AwardsSBFM federal contracts
SBFM doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Congressional TradesWho in Congress is trading SBFM
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
Stock awards & option exercises
Bills to WatchLegislation flagged by our analysis
Political ProfileWhere SBFM sits in Washington
No lobbying activity, zero campaign donations, and no politician trading detected. Stock movement driven by clinical trial results and capital events, not policy.
Regulatory ExposureThreats & opportunities
Regulatory threats
- FDA approval delays
- drug pricing reform
Regulatory opportunities
- orphan drug designation
- accelerated approval pathways
Live signals + predictions for SBFM — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades SBFM
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord